Malek Chamoun
Corporate Officer/Principal bij SUNSHINE BIOPHARMA, INC.
Vermogen: 29 859 $ op 30-04-2024
Profiel
Malek Chamoun is the founder and current President of Nora Pharma, Inc. which is founded in 2017.
He is currently the Chief Development Officer at Sunshine Biopharma, Inc. where he started in 2024.
Mr. Chamoun received his undergraduate degree from Hautes Etudes Commerciales in 2008.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
28-03-2024 | 37 000 ( 3.72% ) | 29 859 $ | 30-04-2024 |
Actieve functies van Malek Chamoun
Bedrijven | Functie | Begin |
---|---|---|
SUNSHINE BIOPHARMA, INC. | Corporate Officer/Principal | 25-01-2024 |
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Oprichter | 01-01-2017 |
Opleiding van Malek Chamoun
Hautes Etudes Commerciales | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SUNSHINE BIOPHARMA, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Distribution Services |